CervoMed Inc. (CRVO)
NASDAQ: CRVO · IEX Real-Time Price · USD
+0.85 (5.64%)
Jul 11, 2024, 4:00 PM EDT - Market closed

CervoMed Statistics

Total Valuation

CervoMed has a market cap or net worth of $131.48 million. The enterprise value is $125.11 million.

Market Cap 131.48M
Enterprise Value 125.11M

Important Dates

The next estimated earnings date is Tuesday, August 6, 2024, after market close.

Earnings Date Aug 6, 2024
Ex-Dividend Date n/a

Share Statistics

CervoMed has 8.25 million shares outstanding. The number of shares has increased by 1,090.89% in one year.

Shares Outstanding 8.25M
Shares Change (YoY) +1,090.89%
Shares Change (QoQ) +131.85%
Owned by Insiders (%) 35.19%
Owned by Institutions (%) 34.85%
Float 3.79M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 20.66
Forward PS 20.79
PB Ratio 24.64
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 19.66
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.99, with zero debt.

Current Ratio 2.99
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -53.00% and return on invested capital (ROIC) is -188.20%.

Return on Equity (ROE) -53.00%
Return on Assets (ROA) -42.40%
Return on Capital (ROIC) -188.20%
Revenue Per Employee $795,539
Profits Per Employee -$604,934
Employee Count 8
Asset Turnover 0.56
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +263.70% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +263.70%
50-Day Moving Average 20.09
200-Day Moving Average 14.42
Relative Strength Index (RSI) 36.33
Average Volume (20 Days) 102,733

Short Selling Information

The latest short interest is 350,711, so 4.25% of the outstanding shares have been sold short.

Short Interest 350,711
Short Previous Month 181,892
Short % of Shares Out 4.25%
Short % of Float 9.25%
Short Ratio (days to cover) 5.25

Income Statement

In the last 12 months, CervoMed had revenue of $6.36 million and -$4.84 million in losses. Loss per share was -$1.12.

Revenue 6.36M
Gross Profit 6.36M
Operating Income -10.04M
Pretax Income -4.84M
Net Income -4.84M
EBIT -4.84M
Loss Per Share -$1.12
Full Income Statement

Balance Sheet

The company has $6.37 million in cash and no debt, giving a net cash position of $6.37 million or $0.77 per share.

Cash & Cash Equivalents 6.37M
Total Debt n/a
Net Cash 6.37M
Net Cash Per Share $0.77
Equity (Book Value) 5.34M
Book Value Per Share 0.65
Working Capital 5.30M
Full Balance Sheet

Cash Flow

Operating Cash Flow -3.91M
Capital Expenditures n/a
Free Cash Flow -3.91M
FCF Per Share -$0.63
Full Cash Flow Statement


Gross margin is 100.00%, with operating and profit margins of -157.80% and -76.04%.

Gross Margin 100.00%
Operating Margin -157.80%
Pretax Margin -76.04%
Profit Margin -76.04%
EBITDA Margin -76.04%
EBIT Margin -76.04%
FCF Margin -61.36%

Dividends & Yields

CervoMed does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1,090.89%
Shareholder Yield -1,090.89%
Earnings Yield -3.68%
FCF Yield -2.97%

Analyst Forecast

The average price target for CervoMed is $66.00, which is 314.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target $66.00
Price Target Difference 314.31%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 38.70%
EPS Growth Forecast (5Y) 70.55%
Stock Forecasts

Stock Splits

The last stock split was on August 17, 2023. It was a reverse split with a ratio of 2:3.

Last Split Date Aug 17, 2023
Split Type Reverse
Split Ratio 2:3


CervoMed has an Altman Z-Score of 19.27 and a Piotroski F-Score of 2.

Altman Z-Score 19.27
Piotroski F-Score 2